Pregnancy: The safety of this medicinal product for use in human pregnancy has not been established in controlled clinical trials and therefore must only be given with caution to pregnant women. Clinical experience with immunoglobulins suggests that no harmful effects on the course of pregnancy, or on the foetus and the neonate are to be expected.
Breastfeeding: The safety of VENBIG for use in human pregnancy has not been established in controlled clinical trials and therefore must only be given with caution to breastfeeding women.
Immunoglobulins are excreted into the milk and may contribute to protecting the neonate.